more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis

April 2013

You'll hear about more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis.

These and other similar drugs might cause inflammation that could lead to acute pancreatitis...and possibly pancreatic cancer.

The big concern is that diabetes already increases the risk of acute pancreatitis...and the drugs might make the risk even higher.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Blood Pressure One in three of your adult patients has high blood pressure
Medication Errors Errors are occurring from abbreviated drug names
Dermatology Topical retinoid Rxs (Differin, Retin-A, Tazorac, etc) often cause dispensing challenges
Cholesterol Patients often stop their cholesterol-lowering meds because they don't "feel" sick
Headache Patients may be surprised to learn that their headache medication can lead to MORE headaches
Antibiotics fewer antibiotic Rxs for ear infections
Opioids the dangers of using codeine in kids
Vitamins & Minerals questions about the safety and efficacy of calcium and vitamin D supplements
Diabetes Meds more concerns that exenatide (Byetta, etc) and sitagliptin (Januvia, etc) might increase the risk of pancreatitis
Antibiotics new focus on IV antibiotics for patients having surgery
Constipation myths about constipation
Beta-Blockers new "beta-blocker" called Bystolic (buy-STOL-ic, nebivolol) for treating high blood pressure